Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.81 USD | +1.59% |
|
+5.01% | -40.42% |
| May. 19 | Leerink Partners Adjusts Boston Scientific PT to $87 From $86, Maintains Outperform Rating | MT |
| May. 19 | Boston Scientific Catheter Says Trial Meets Safety, Effectiveness Goals | MT |
| Capitalization | 84.44B 72.83B 66.72B 63.04B 116B 8,175B 119B 795B 310B 3,848B 317B 310B 13,439B | P/E ratio 2026 * |
21x | P/E ratio 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise value | 90.73B 78.26B 71.69B 67.74B 125B 8,784B 128B 854B 333B 4,135B 340B 333B 14,440B | EV / Sales 2026 * |
4.18x | EV / Sales 2027 * | 3.71x |
| Free-Float |
84.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +1.59% | ||
| 1 week | +5.01% | ||
| Current month | -1.39% | ||
| 1 month | -11.55% | ||
| 3 months | -24.97% | ||
| 6 months | -41.44% | ||
| Current year | -40.42% |
| 1 week | 52.52 |  | 57.59 |
| 1 month | 52.52 | | 66.88 |
| Current year | 52.52 | | 100.9 |
| 1 year | 52.52 | | 109.5 |
| 3 years | 48.35 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 2011-10-31 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 2025-06-29 |
John Sorenson
COO | Chief Operating Officer | 58 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 74 | 2014-02-28 |
Ellen Zane
BRD | Director/Board Member | 74 | 2016-04-14 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.38% | 1.75% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.59% | +5.01% | -46.74% | +5.91% | 83.12B | |
| +1.31% | -2.50% | +8.19% | -15.09% | 164B | |
| +0.38% | +2.25% | -21.38% | +40.81% | 156B | |
| +1.94% | +0.47% | -14.95% | -26.84% | 116B | |
| -0.28% | +3.05% | +5.28% | -6.56% | 47.44B | |
| +0.59% | -0.12% | -31.21% | -37.09% | 43.71B | |
| +0.32% | -5.38% | -7.05% | +24.59% | 32.62B | |
| -1.37% | -2.06% | -2.53% | -14.20% | 31.68B | |
| +1.78% | +1.96% | -17.99% | -7.45% | 29.61B | |
| +0.11% | -1.14% | -15.76% | -22.38% | 27.98B | |
| Average | +0.64% | +0.66% | -14.41% | -5.83% | 73.22B | |
| Weighted average by Cap. | +0.91% | +0.52% | -13.66% | -1.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.68B 18.7B 17.13B 16.19B 29.84B 2,099B 30.59B 204B 79.5B 988B 81.36B 79.62B 3,450B | 23.57B 20.33B 18.62B 17.6B 32.44B 2,282B 33.26B 222B 86.42B 1,074B 88.45B 86.56B 3,751B |
| Net income | 3.92B 3.38B 3.1B 2.93B 5.4B 380B 5.54B 36.94B 14.39B 179B 14.72B 14.41B 624B | 4.17B 3.6B 3.29B 3.11B 5.74B 404B 5.88B 39.26B 15.29B 190B 15.65B 15.31B 664B |
| Net Debt | 6.29B 5.43B 4.97B 4.7B 8.66B 609B 8.88B 59.26B 23.08B 287B 23.62B 23.12B 1,002B | 2.9B 2.5B 2.29B 2.16B 3.99B 281B 4.09B 27.3B 10.63B 132B 10.88B 10.65B 461B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-19 | 56.81 $ | +1.59% | 22,605,177 |
| 26-05-18 | 55.92 $ | +6.15% | 16,769,062 |
| 26-05-15 | 52.68 $ | -1.62% | 14,843,339 |
| 26-05-14 | 53.55 $ | +0.92% | 14,595,126 |
| 26-05-13 | 53.06 $ | -1.92% | 17,994,229 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
